Share Price and Basic Stock Data
Last Updated: November 20, 2025, 12:24 am
| PEG Ratio | 12.05 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Goldcoin Health Foods Ltd operates in the food processing sector, specifically focusing on bakery, dairy, and fruit products. The company recorded a share price of ₹14.6 and a market capitalization of ₹4.37 Cr. Over the past several years, Goldcoin’s revenue has shown a declining trend, with sales standing at ₹0.04 Cr in March 2023 and rising slightly to ₹0.07 Cr in March 2025, reflecting a marginal recovery. The trailing twelve months (TTM) sales reached ₹0.08 Cr, indicating a slow upward movement. However, this revenue remains significantly low compared to industry standards, where many food processing companies report sales in several hundred crores. The company’s operational performance has been hindered by persistent low sales and high operating expenses, impacting overall profitability.
Profitability and Efficiency Metrics
Goldcoin Health Foods has struggled with profitability, as evidenced by its negative operating profit margin (OPM) of -350.00% in the latest quarter. Historical data shows that the company has consistently recorded operating losses, with the OPM reaching as low as -2,575.00% in March 2023. The net profit for the latest quarter was ₹0.01 Cr, which is negligible compared to total expenses of ₹0.34 Cr for March 2024. Additionally, the company’s return on equity (ROE) stood at 11.1%, while return on capital employed (ROCE) was at a low 8.76%. The cash conversion cycle (CCC) was alarmingly high at 4,484.29 days, indicating inefficiencies in converting sales into cash flow. These metrics highlight significant challenges in managing costs effectively while generating revenue.
Balance Sheet Strength and Financial Ratios
Goldcoin Health Foods’ balance sheet reflects a precarious financial position, with no reported reserves or borrowings, suggesting a lack of leverage but also limited financial flexibility. The company’s price-to-book value (P/BV) ratio stands at 2.69x, indicating that the stock is trading at a premium relative to its book value of ₹3.39 per share as of March 2025. The interest coverage ratio (ICR) of -28.84x further emphasizes the company’s inability to cover its interest obligations, raising concerns about its financial viability. Additionally, the current ratio is recorded at 1.48, which is acceptable but must be viewed in conjunction with the company’s negative profitability trends. Overall, the balance sheet metrics suggest that while Goldcoin may not be heavily leveraged, its operational inefficiencies and inability to generate sufficient profits pose significant risks to its financial stability.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Goldcoin Health Foods indicates a strong presence of public shareholders, who own 60.69% of the company, while promoters hold 39.31%. The number of shareholders has increased from 2,181 in December 2022 to 3,249 by March 2025, suggesting growing interest from retail investors despite the company’s financial challenges. However, the lack of Foreign Institutional Investors (FIIs) and Domestic Institutional Investors (DIIs) may reflect a lack of confidence from larger institutional players in the company’s future prospects. The consistent promoter holding indicates stability in governance, yet the overall investor sentiment could be dampened by the company’s ongoing operational struggles and low profitability, which may deter potential investments from institutional entities.
Outlook, Risks, and Final Insight
Goldcoin Health Foods faces a challenging outlook, primarily due to its ongoing operational inefficiencies and negative profitability metrics. The high cash conversion cycle and low sales figures suggest that the company must implement significant operational improvements to enhance its financial health. Risks include continued negative profitability, potential liquidity issues, and a lack of institutional support. However, should the company manage to streamline operations and improve its revenue generation, there is potential for recovery. The increase in the number of retail shareholders may provide a support base for future fundraising efforts. A strategic turnaround focusing on cost management and market positioning could offer a pathway to stabilize and potentially enhance profitability in the coming years.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Goldcoin Health Foods Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Mishtann Foods Ltd | 543 Cr. | 5.04 | 15.9/4.28 | 1.62 | 10.9 | 0.00 % | 42.2 % | 44.1 % | 1.00 |
| Mrs Bectors Food Specialities Ltd | 8,086 Cr. | 1,317 | 1,977/1,201 | 59.4 | 198 | 0.46 % | 18.1 % | 15.6 % | 10.0 |
| Nakoda Group of Industries Ltd | 49.5 Cr. | 28.3 | 48.0/25.2 | 18.8 | 0.00 % | 8.11 % | 15.4 % | 10.0 | |
| HMA Agro Industries Ltd | 1,574 Cr. | 31.5 | 48.3/27.5 | 18.2 | 15.8 | 0.95 % | 11.8 % | 11.5 % | 1.00 |
| Himalaya Food International Ltd | 87.3 Cr. | 10.3 | 19.8/9.29 | 15.2 | 21.8 | 0.00 % | 2.29 % | 2.79 % | 10.0 |
| Industry Average | 21,619.57 Cr | 749.49 | 133.12 | 106.55 | 0.24% | 16.32% | 17.50% | 6.03 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 |
| Expenses | 0.02 | 0.06 | 0.02 | 0.03 | 0.02 | 0.01 | 0.05 | 0.11 | 0.02 | 0.11 | 0.04 | 0.04 | 0.09 |
| Operating Profit | -0.01 | -0.05 | -0.01 | -0.02 | -0.01 | 0.00 | -0.04 | -0.10 | -0.01 | -0.09 | -0.02 | -0.02 | -0.07 |
| OPM % | -100.00% | -500.00% | -100.00% | -200.00% | -100.00% | 0.00% | -400.00% | -1,000.00% | -100.00% | -450.00% | -100.00% | -100.00% | -350.00% |
| Other Income | 0.00 | 0.00 | -0.83 | -0.11 | -0.12 | 0.00 | -0.01 | -0.01 | 0.00 | 0.00 | 0.00 | 0.02 | 0.12 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | -0.01 | 0.00 |
| Profit before tax | -0.02 | -0.06 | -0.85 | -0.14 | -0.14 | -0.01 | -0.06 | -0.12 | -0.02 | -0.10 | -0.03 | 0.01 | 0.05 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 40.00% |
| Net Profit | -0.01 | -0.05 | -0.84 | -0.13 | -0.13 | -0.01 | -0.06 | -0.12 | -0.02 | -0.09 | -0.03 | 0.01 | 0.04 |
| EPS in Rs | -0.03 | -0.17 | -2.80 | -0.43 | -0.43 | -0.03 | -0.20 | -0.40 | -0.07 | -0.30 | -0.10 | 0.03 | 0.13 |
Last Updated: August 19, 2025, 2:35 pm
Below is a detailed analysis of the quarterly data for Goldcoin Health Foods Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 0.02 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.02 Cr..
- For Expenses, as of Jun 2025, the value is 0.09 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.04 Cr. (Mar 2025) to 0.09 Cr., marking an increase of 0.05 Cr..
- For Operating Profit, as of Jun 2025, the value is -0.07 Cr.. The value appears to be declining and may need further review. It has decreased from -0.02 Cr. (Mar 2025) to -0.07 Cr., marking a decrease of 0.05 Cr..
- For OPM %, as of Jun 2025, the value is -350.00%. The value appears to be declining and may need further review. It has decreased from -100.00% (Mar 2025) to -350.00%, marking a decrease of 250.00%.
- For Other Income, as of Jun 2025, the value is 0.12 Cr.. The value appears strong and on an upward trend. It has increased from 0.02 Cr. (Mar 2025) to 0.12 Cr., marking an increase of 0.10 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Depreciation, as of Jun 2025, the value is 0.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from -0.01 Cr. (Mar 2025) to 0.00 Cr., marking an increase of 0.01 Cr..
- For Profit before tax, as of Jun 2025, the value is 0.05 Cr.. The value appears strong and on an upward trend. It has increased from 0.01 Cr. (Mar 2025) to 0.05 Cr., marking an increase of 0.04 Cr..
- For Tax %, as of Jun 2025, the value is 40.00%. The value appears to be increasing, which may not be favorable. It has increased from 0.00% (Mar 2025) to 40.00%, marking an increase of 40.00%.
- For Net Profit, as of Jun 2025, the value is 0.04 Cr.. The value appears strong and on an upward trend. It has increased from 0.01 Cr. (Mar 2025) to 0.04 Cr., marking an increase of 0.03 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.13. The value appears strong and on an upward trend. It has increased from 0.03 (Mar 2025) to 0.13, marking an increase of 0.10.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 3:14 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2.96 | 3.22 | 2.54 | 1.74 | 0.94 | 0.69 | 0.36 | 0.16 | 0.07 | 0.04 | 0.04 | 0.07 | 0.08 |
| Expenses | 2.88 | 3.12 | 2.51 | 1.79 | 0.91 | 0.75 | 0.40 | 0.20 | 1.17 | 1.07 | 0.34 | 0.21 | 0.21 |
| Operating Profit | 0.08 | 0.10 | 0.03 | -0.05 | 0.03 | -0.06 | -0.04 | -0.04 | -1.10 | -1.03 | -0.30 | -0.14 | -0.13 |
| OPM % | 2.70% | 3.11% | 1.18% | -2.87% | 3.19% | -8.70% | -11.11% | -25.00% | -1,571.43% | -2,575.00% | -750.00% | -200.00% | -162.50% |
| Other Income | 0.00 | 0.01 | 0.01 | 0.16 | 0.02 | 0.08 | 0.04 | 0.00 | 0.02 | 0.02 | 0.01 | 0.02 | 0.14 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 |
| Depreciation | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.00 | 0.00 |
| Profit before tax | 0.06 | 0.09 | 0.02 | 0.09 | 0.03 | 0.00 | -0.02 | -0.06 | -1.10 | -1.04 | -0.32 | -0.12 | 0.01 |
| Tax % | 33.33% | 33.33% | 50.00% | 11.11% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||
| Net Profit | 0.04 | 0.06 | 0.01 | 0.07 | 0.03 | 0.00 | -0.02 | -0.05 | -1.10 | -1.04 | -0.32 | -0.12 | 0.01 |
| EPS in Rs | 0.13 | 0.20 | 0.03 | 0.23 | 0.10 | 0.00 | -0.07 | -0.17 | -3.67 | -3.47 | -1.07 | -0.40 | 0.03 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 50.00% | -83.33% | 600.00% | -57.14% | -100.00% | -150.00% | -2100.00% | 5.45% | 69.23% | 62.50% |
| Change in YoY Net Profit Growth (%) | 0.00% | -133.33% | 683.33% | -657.14% | -42.86% | -50.00% | -1950.00% | 2105.45% | 63.78% | -6.73% |
Goldcoin Health Foods Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -32% |
| 5 Years: | -28% |
| 3 Years: | 0% |
| TTM: | 100% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 24% |
| TTM: | 63% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -13% |
| 5 Years: | 16% |
| 3 Years: | 2% |
| 1 Year: | 45% |
| Return on Equity | |
|---|---|
| 10 Years: | -9% |
| 5 Years: | -23% |
| 3 Years: | -33% |
| Last Year: | -11% |
Last Updated: September 5, 2025, 3:36 pm
No data available for the Balance Sheet data table.
Cash Flow - No data available for this post.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 50.56 | 73.68 | 104.90 | 157.33 | 326.17 | 518.41 | 1,024.03 | 2,281.25 | 4,275.71 | 7,847.50 | 7,847.50 | 4,484.29 |
| Inventory Days | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 50.56 | 73.68 | 104.90 | 157.33 | 326.17 | 518.41 | 1,024.03 | 2,281.25 | 4,275.71 | 7,847.50 | 7,847.50 | 4,484.29 |
| Working Capital Days | 49.32 | 68.01 | 102.03 | 151.03 | 287.34 | 460.22 | 1,652.64 | 2,030.31 | 2,190.00 | 5,657.50 | 4,288.75 | -208.57 |
| ROCE % | 2.12% | 2.51% | 0.55% | -0.82% | 0.81% | 0.00% | -0.54% | -1.63% | -33.80% | -43.83% | -18.40% | -8.76% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -0.41 | -1.07 | -3.46 | -3.68 | -0.17 |
| Diluted EPS (Rs.) | -0.41 | -1.07 | -3.46 | -3.68 | -0.17 |
| Cash EPS (Rs.) | -0.40 | -1.00 | -3.39 | -3.61 | -0.10 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 3.39 | 3.80 | 5.02 | 8.48 | 12.16 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 3.39 | 3.80 | 5.02 | 8.48 | 12.16 |
| Revenue From Operations / Share (Rs.) | 0.21 | 0.11 | 0.13 | 0.23 | 0.52 |
| PBDIT / Share (Rs.) | -0.39 | -0.97 | -3.37 | -3.60 | -0.12 |
| PBIT / Share (Rs.) | -0.39 | -1.04 | -3.44 | -3.67 | -0.18 |
| PBT / Share (Rs.) | -0.40 | -1.06 | -3.46 | -3.68 | -0.18 |
| Net Profit / Share (Rs.) | -0.40 | -1.07 | -3.46 | -3.68 | -0.17 |
| PBDIT Margin (%) | -180.49 | -827.13 | -2474.72 | -1543.69 | -23.32 |
| PBIT Margin (%) | -181.37 | -883.85 | -2523.73 | -1572.32 | -36.07 |
| PBT Margin (%) | -187.63 | -900.96 | -2539.71 | -1577.25 | -36.10 |
| Net Profit Margin (%) | -187.63 | -909.51 | -2539.71 | -1577.25 | -33.45 |
| Return on Networth / Equity (%) | -11.99 | -28.16 | -68.85 | -43.35 | -1.43 |
| Return on Capital Employeed (%) | -9.51 | -22.18 | -55.96 | -39.25 | -1.55 |
| Return On Assets (%) | -5.57 | -17.58 | -49.26 | -37.07 | -1.39 |
| Long Term Debt / Equity (X) | 0.21 | 0.23 | 0.22 | 0.10 | 0.00 |
| Total Debt / Equity (X) | 0.24 | 0.28 | 0.25 | 0.10 | 0.00 |
| Asset Turnover Ratio (%) | 0.03 | 0.01 | 0.01 | 0.02 | 0.04 |
| Current Ratio (X) | 1.48 | 2.12 | 3.34 | 4.94 | 9.09 |
| Quick Ratio (X) | 1.48 | 2.12 | 3.34 | 4.94 | 9.09 |
| Interest Coverage Ratio (X) | -28.84 | -48.33 | -154.86 | -313.01 | -826.37 |
| Interest Coverage Ratio (Post Tax) (X) | -28.98 | -52.14 | -157.92 | -318.81 | -1184.34 |
| Enterprise Value (Cr.) | 2.50 | 2.64 | 2.12 | 2.47 | 1.08 |
| EV / Net Operating Revenue (X) | 38.35 | 74.70 | 51.88 | 35.37 | 6.91 |
| EV / EBITDA (X) | -21.25 | -9.03 | -2.10 | -2.29 | -29.64 |
| MarketCap / Net Operating Revenue (X) | 42.06 | 65.44 | 42.59 | 31.78 | 6.94 |
| Price / BV (X) | 2.69 | 2.03 | 1.15 | 0.87 | 0.29 |
| Price / Net Operating Revenue (X) | 42.22 | 65.81 | 42.65 | 31.80 | 6.94 |
| EarningsYield | -0.04 | -0.13 | -0.59 | -0.49 | -0.04 |
After reviewing the key financial ratios for Goldcoin Health Foods Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -0.41. This value is below the healthy minimum of 5. It has increased from -1.07 (Mar 24) to -0.41, marking an increase of 0.66.
- For Diluted EPS (Rs.), as of Mar 25, the value is -0.41. This value is below the healthy minimum of 5. It has increased from -1.07 (Mar 24) to -0.41, marking an increase of 0.66.
- For Cash EPS (Rs.), as of Mar 25, the value is -0.40. This value is below the healthy minimum of 3. It has increased from -1.00 (Mar 24) to -0.40, marking an increase of 0.60.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 3.39. It has decreased from 3.80 (Mar 24) to 3.39, marking a decrease of 0.41.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 3.39. It has decreased from 3.80 (Mar 24) to 3.39, marking a decrease of 0.41.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 0.21. It has increased from 0.11 (Mar 24) to 0.21, marking an increase of 0.10.
- For PBDIT / Share (Rs.), as of Mar 25, the value is -0.39. This value is below the healthy minimum of 2. It has increased from -0.97 (Mar 24) to -0.39, marking an increase of 0.58.
- For PBIT / Share (Rs.), as of Mar 25, the value is -0.39. This value is below the healthy minimum of 0. It has increased from -1.04 (Mar 24) to -0.39, marking an increase of 0.65.
- For PBT / Share (Rs.), as of Mar 25, the value is -0.40. This value is below the healthy minimum of 0. It has increased from -1.06 (Mar 24) to -0.40, marking an increase of 0.66.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -0.40. This value is below the healthy minimum of 2. It has increased from -1.07 (Mar 24) to -0.40, marking an increase of 0.67.
- For PBDIT Margin (%), as of Mar 25, the value is -180.49. This value is below the healthy minimum of 10. It has increased from -827.13 (Mar 24) to -180.49, marking an increase of 646.64.
- For PBIT Margin (%), as of Mar 25, the value is -181.37. This value is below the healthy minimum of 10. It has increased from -883.85 (Mar 24) to -181.37, marking an increase of 702.48.
- For PBT Margin (%), as of Mar 25, the value is -187.63. This value is below the healthy minimum of 10. It has increased from -900.96 (Mar 24) to -187.63, marking an increase of 713.33.
- For Net Profit Margin (%), as of Mar 25, the value is -187.63. This value is below the healthy minimum of 5. It has increased from -909.51 (Mar 24) to -187.63, marking an increase of 721.88.
- For Return on Networth / Equity (%), as of Mar 25, the value is -11.99. This value is below the healthy minimum of 15. It has increased from -28.16 (Mar 24) to -11.99, marking an increase of 16.17.
- For Return on Capital Employeed (%), as of Mar 25, the value is -9.51. This value is below the healthy minimum of 10. It has increased from -22.18 (Mar 24) to -9.51, marking an increase of 12.67.
- For Return On Assets (%), as of Mar 25, the value is -5.57. This value is below the healthy minimum of 5. It has increased from -17.58 (Mar 24) to -5.57, marking an increase of 12.01.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.21. This value is within the healthy range. It has decreased from 0.23 (Mar 24) to 0.21, marking a decrease of 0.02.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.24. This value is within the healthy range. It has decreased from 0.28 (Mar 24) to 0.24, marking a decrease of 0.04.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.03. It has increased from 0.01 (Mar 24) to 0.03, marking an increase of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 1.48. This value is below the healthy minimum of 1.5. It has decreased from 2.12 (Mar 24) to 1.48, marking a decrease of 0.64.
- For Quick Ratio (X), as of Mar 25, the value is 1.48. This value is within the healthy range. It has decreased from 2.12 (Mar 24) to 1.48, marking a decrease of 0.64.
- For Interest Coverage Ratio (X), as of Mar 25, the value is -28.84. This value is below the healthy minimum of 3. It has increased from -48.33 (Mar 24) to -28.84, marking an increase of 19.49.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -28.98. This value is below the healthy minimum of 3. It has increased from -52.14 (Mar 24) to -28.98, marking an increase of 23.16.
- For Enterprise Value (Cr.), as of Mar 25, the value is 2.50. It has decreased from 2.64 (Mar 24) to 2.50, marking a decrease of 0.14.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 38.35. This value exceeds the healthy maximum of 3. It has decreased from 74.70 (Mar 24) to 38.35, marking a decrease of 36.35.
- For EV / EBITDA (X), as of Mar 25, the value is -21.25. This value is below the healthy minimum of 5. It has decreased from -9.03 (Mar 24) to -21.25, marking a decrease of 12.22.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 42.06. This value exceeds the healthy maximum of 3. It has decreased from 65.44 (Mar 24) to 42.06, marking a decrease of 23.38.
- For Price / BV (X), as of Mar 25, the value is 2.69. This value is within the healthy range. It has increased from 2.03 (Mar 24) to 2.69, marking an increase of 0.66.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 42.22. This value exceeds the healthy maximum of 3. It has decreased from 65.81 (Mar 24) to 42.22, marking a decrease of 23.59.
- For EarningsYield, as of Mar 25, the value is -0.04. This value is below the healthy minimum of 5. It has increased from -0.13 (Mar 24) to -0.04, marking an increase of 0.09.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Goldcoin Health Foods Ltd:
- Net Profit Margin: -187.63%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -9.51% (Industry Average ROCE: 16.32%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -11.99% (Industry Average ROE: 17.5%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -28.98
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.48
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 437 (Industry average Stock P/E: 133.12)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.24
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -187.63%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Food Processing - Bakery/Dairy/Fruits/Others | A-16, 1st Floor, Vardan Tower, Pragatinagar, Naranpura, Ahmedabad Gujarat 380013 | goldcoinhealth@gmail.com www.goldcoinhealthfoods.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Devang Shah | Managing Director & CEO |
| Mrs. Pravinaben Gohil | Director |
| Mr. Ashok Solanki | Independent Director |
| Mr. Hiren Mehta | Independent Director |